PHARMACY

Novo Nordisk, Teva ink generic Victoza settlement
Teva is licensed to launch a generic version of Victoza as of Dec. 22, 2023 as the result of its settlement with Novo Nordisk, which manufactures the branded version of the drug.
FDA approves Zydus Cadila’s generic Zovirax ointment
Zydus Cadila's generic Zovirax will be available in 5% strength.

NACDS praises 7-day prescription bill to mitigate opioid abuse

The legislation would help prevent addiction and abuse, and help prevent opioids from falling into the wrong hands.
West Virginia Medicaid saves $54.4M with prescription drug carve out

The prescription drug carve out resulted in $122 million in pharmacy dispensing fees to West Virginia pharmacies.
FDA approves pediatric indication for Allergan’s Avycaz

This is the first Food and Drug Administration approval of a pediatric indication for complicated intra-abdominal infections and complicated urinary tract infections in more than a decade, Allergan said.
Zydus Cadila gets FDA clearance for generic Diovan

Zydus Cadila's generic Diovan tablets come in several dosage strengths.
Diplomat posts Q4 loss, names new CFO

Despite seeing revenue growth from its recently launched PBM segment and increases in revenue and gross profits, Diplomat Pharmacy posted a net loss of $298 million for the fourth quarter.
Amplicare, Ananda Professional to bring automated CBD, wellness education to pharmacies

The new software will enable pharmacists to identify patients who can benefit from CBD products.
Glenmark receives FDA approval for generic BenzaClin gel

BenzaClin gel had a market value of roughly $99.4 million for the 12 months ended January 2019.
NACDS praises Arkansas e-prescribing law preventing opioid abuse

The bill, which requires electronic prescribing of Schedules I through VI controlled substances, goes into effect Jan. 1, 2021.